6 completed, 1 terminated. 7 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 6, Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow arhalofenate: new trials by email Literature Review of arhalofenate trials Research Report on arhalofenate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With Gout Arhalofenate, Febuxostat, Colchicine - Gout, Hyperuricemia | Phase 2 | Completed | Gilead Sciences | 32 | 2014-08-01 | 2026-09-18 |
| Evaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout Patients Arhalofenate 600 mg, Allopurinol 300 mg, Colchicine 0.6 mg - Gout | Phase 2 | Completed | Gilead Sciences | 248 | 2014-03-01 | 2018-01-29 |
| Open Label Safety/Efficacy Study of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Gout Patients Arhalofenate, Febuxostat, Colchicine - Hyperuricemia, Gout | Phase 2 | Completed | Gilead Sciences | 27 | 2011-08-01 | 2015-04-03 |
| Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients Arhalofenate, Allopurinol, Colchicine - Gout | Phase 2 | Completed | Gilead Sciences | 100 | 2011-06-01 | 2015-09-18 |
| Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With Gout Arhalofenate, Placebo comparator, Colchicine - Hyperuricemia, Gout | Phase 2 | Completed | Gilead Sciences | 67 | 2011-05-01 | 2026-09-18 |
| Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on Metformin MBX-102, Placebo, Actos - Type 2 Diabetes Mellitus | Phase 2 | Terminated | Gilead Sciences | 242 | 2008-12-01 | 2026-09-18 |
| Safety and Efficacy Study of Metaglidasen in Type 2 Diabetes in Patients Suboptimally Controlled on Insulin MBX-102, Placebo, Actos - Type 2 Diabetes | Phase 2 / Phase 3 | Completed | Gilead Sciences | 396 | 2006-05-01 | 2015-05-01 |
Gout (5) · Hyperuricemia (4) · Diabetes Mellitus, Type 2 (2) · Diabetes Mellitus (1)
Gilead Sciences (7)
United States (7) · Canada (2) · Georgia (2) · India (2) · Argentina (1) · Israel (1)
Abhay Mutha, MD (1) · Alexandra Steinberg, MD, PhD (1) · Aravind S Sosale, MD (1) · Ariachery C Ammini, MD (1) · Douglas Denham, M.D. (1) · Ganapati Bantwal, MD (1) · Harish Kumar, MD (1) · K. M. Prasanna Kumar, MD (1) · Kirtikumar Modi, MD (1) · Manoj Chadha, MD (1) · Mathew Thomas, MD (1) · Michael Guice, M.D. (1) · Navneet Agrawal, MD (1) · Nihal Thomas, MD (1) · Prabha Adhikari, MD (1)